Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma

PURPOSE: This phase I clinical trial was conducted to determine the safety, efficacy, and molecular effects of sorafenib with temsirolimus in patients with advanced melanoma. PATIENTS AND METHODS: Patients with stage IV or unresectable or recurrent stage III melanoma and ECOG performance status of 0...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Davies, Michael A., Fox, Patricia S., Papadopoulos, Nicholas E., Bedikian, Agop Y., Hwu, Wen-Jen, Lazar, Alexander J. F., Prieto, Victor G., Culotta, Kirk S., Madden, Timothy L., Xu, Quanyun, Huang, Sha, Deng, Wanleng, Ng, Chaan, Gupta, Sanjay, Liu, Wenbin, Dancey, Janet E., Wright, John J., Bassett, Roland L., Hwu, Patrick, Kim, Kevin B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906678/
https://ncbi.nlm.nih.gov/pubmed/22223528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2436
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados